Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+8.19%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$2.51B
Cap. Flow %
-3.43%
Top 10 Hldgs %
11.25%
Holding
4,601
New
625
Increased
1,395
Reduced
2,029
Closed
525

Top Buys

1
AAPL icon
Apple
AAPL
+$763M
2
AMZN icon
Amazon
AMZN
+$688M
3
TSM icon
TSMC
TSM
+$562M
4
TSLA icon
Tesla
TSLA
+$419M
5
JNJ icon
Johnson & Johnson
JNJ
+$398M

Sector Composition

1 Healthcare 20.8%
2 Technology 15.52%
3 Consumer Discretionary 11.85%
4 Consumer Staples 10.11%
5 Financials 9.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TSVT
3451
DELISTED
2seventy bio
TSVT
$181K ﹤0.01%
+19,300
New +$181K
USCB icon
3452
USCB Financial Holdings
USCB
$349M
$181K ﹤0.01%
14,800
-400
-3% -$4.89K
GOCO icon
3453
GoHealth
GOCO
$79.6M
$180K ﹤0.01%
17,272
-22,952
-57% -$239K
TARA icon
3454
Protara Therapeutics
TARA
$121M
$180K ﹤0.01%
67,000
-12,200
-15% -$32.8K
LUXE
3455
LuxExperience B.V. American Depositary Shares, each representing one Ordinary Share
LUXE
$1.25B
$179K ﹤0.01%
+20,131
New +$179K
NAUT icon
3456
Nautilus Biotechnolgy
NAUT
$91M
$179K ﹤0.01%
99,500
+10,400
+12% +$18.7K
HGEN
3457
DELISTED
HUMANIGEN, INC.
HGEN
$179K ﹤0.01%
1,491,771
+626,071
+72% +$75.1K
FOA icon
3458
Finance of America Companies
FOA
$278M
$178K ﹤0.01%
13,990
-870
-6% -$11.1K
NISN icon
3459
NiSun International Enterprise Development Group
NISN
$16.9M
$178K ﹤0.01%
31,178
+2,719
+10% +$15.5K
SSBI icon
3460
Summit State Bank
SSBI
$80.9M
$178K ﹤0.01%
+11,290
New +$178K
GTH
3461
DELISTED
Genetron Holdings Limited ADS
GTH
$178K ﹤0.01%
53,033
+700
+1% +$2.35K
SIOX
3462
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$178K ﹤0.01%
409,284
+47,284
+13% +$20.6K
ATNX
3463
DELISTED
Athenex, Inc. Common Stock
ATNX
$178K ﹤0.01%
60,276
+17,198
+40% +$50.8K
GLTO icon
3464
Galecto
GLTO
$3.8M
$177K ﹤0.01%
6,160
-1,012
-14% -$29.1K
BRBS icon
3465
Blue Ridge Bankshares
BRBS
$380M
$176K ﹤0.01%
14,100
+3,900
+38% +$48.7K
APTX
3466
DELISTED
Aptinyx Inc. Common Stock
APTX
$176K ﹤0.01%
618,226
+77,200
+14% +$22K
NERV icon
3467
Minerva Neurosciences
NERV
$15.2M
$175K ﹤0.01%
110,300
+8,500
+8% +$13.5K
CLVR
3468
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$175K ﹤0.01%
18,977
-83
-0.4% -$765
ABOS icon
3469
Acumen Pharmaceuticals
ABOS
$80M
$174K ﹤0.01%
+32,300
New +$174K
ML
3470
DELISTED
MoneyLion Inc.
ML
$174K ﹤0.01%
9,333
+1,413
+18% +$26.3K
PNT
3471
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$173K ﹤0.01%
23,700
-16,000
-40% -$117K
CLAR icon
3472
Clarus
CLAR
$147M
$171K ﹤0.01%
21,790
-103,000
-83% -$808K
IBIO icon
3473
iBio
IBIO
$18.3M
$170K ﹤0.01%
19,080
+16,504
+641% +$147K
SYRS
3474
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$170K ﹤0.01%
47,235
+3,500
+8% +$12.6K
CCM
3475
Concord Medical Services
CCM
$24.8M
$169K ﹤0.01%
10,310
-950
-8% -$15.6K